SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-018749
Filing Date
2021-04-14
Accepted
2021-04-13 18:49:42
Documents
14
Period of Report
2021-04-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sybx-8k_20210410.htm   iXBRL 8-K 44089
2 EX-99.1 d156442dex991.htm EX-99.1 7697
3 EX-99.2 d156442dex992.htm EX-99.2 7559
  Complete submission text file 0001564590-21-018749.txt   197153

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA sybx-20210410.xsd EX-101.SCH 5768
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sybx-20210410_lab.xml EX-101.LAB 19480
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sybx-20210410_pre.xml EX-101.PRE 11626
7 EXTRACTED XBRL INSTANCE DOCUMENT sybx-8k_20210410_htm.xml XML 3515
Mailing Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142 617-401-9975
SYNLOGIC, INC. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37566 | Film No.: 21824167
SIC: 2834 Pharmaceutical Preparations